Login To Trade  |  About IIFL
  • NIFTY  8427.8  -57.1 -0.67%
  • SENSEX 27864.4  -228.39 -0.81%

Time-Cap effect! Marksans Pharma rallies 17%

India Infoline News Service | Mumbai | July 06, 2015 10:27 IST

Time-Cap is a manufacturer and marketer of solid dose generic pharmaceuticals, including private label over-the-counter medications, generic prescription drugs and nutritional supplements.

Arvind Remedies hits upper circuit on hopes of fresh investment

India Infoline News Service | Mumbai | July 06, 2015 09:56 IST

The company informed the BSE, the board will meet on 11 July, 2015 to consider the proposal for investment in the company by a potential investor.

Bliss GVS Pharma hits 20% upper circuit after order win

India Infoline News Service | Mumbai | July 03, 2015 16:17 IST

The companywon a $ 35 million contract for Medical Healthcare Services in Kenya.The total traded quantity was 5.25 lakh shares and two-week average quantity is 1.52 lakh.

Bliss GVS Pharma hits 20% upper circuit

India Infoline News Service | Mumbai | July 03, 2015 11:27 IST

The company has bagged USD 35 million contract for Medical Healthcare Services in Kenya.

Lupin jumps 2% on acquiring Russian firm

India Infoline News Service | Mumbai | July 03, 2015 09:30 IST

Lupin has acquired 100 percent equity stake in ZAO 'Biocom' in Russia. The stock has now jumped over 2 percent on the BSE.

Sun Pharma to optimize manufacturing network

India Infoline News Service | Mumbai | July 03, 2015 08:50 IST

Currently, 25% of Suns business comes from the Indian market, adding Rs. 7,000 crore to the total revenue kitty of Rs. 25,000 crore.

Lupin acquires 100% equity stake in ZAO Biocom in Russia

India Infoline News Service | Mumbai | July 02, 2015 18:23 IST

The acquisition marks Lupin's foray into the Russian pharmaceutical market which recorded RUB 765 billion in sales, placing it as one of the Top 10 pharmaceutical markets in the world in 2014 (IMS Health). For over a decade, Russian pharmaceutical market recorded double digit growth and expected to continue with this trend, projecting Russia to be one of the top 8 pharmaceutical markets in the world by 2018.

Alembic Pharma surges 2.5% after getting approval for antidepressant drug

India Infoline News Service | Mumbai | July 02, 2015 16:12 IST

The pharma company receive US FDA nod for antidepressant drug Desvenlafaxine Succinate. The stock hit a high of Rs. 679 and low of Rs. 666 on BSE today.

Sanofi India plans to sell Chakala property; up 1%

India Infoline News Service | Mumbai | July 02, 2015 13:48 IST

The stock has hit a high of Rs. 3,600 and a low of Rs. 3,410.05 on BSE today.

Sun Pharma arm Taro gets US FDA nod for generic of Clarinex

India Infoline News Service | Mumbai | July 02, 2015 11:59 IST

The stock has hit a high of Rs. 883 and a low of Rs. 873.

Strides Arcolab rallies as RBI lifts curb

India Infoline News Service | Mumbai | July 02, 2015 10:37 IST

The stock has surged over 2 percent as fresh buying by FIIs is now allowed by the Central Bank.

Alembic Pharma, Lupin up on nod for antidepressant drug

India Infoline News Service | Mumbai | July 02, 2015 09:24 IST

The stocks have gained up to 2 percent in early morning trade.

Dr. Reddys unveils New Corporate Brand Identity

India Infoline News Service | Mumbai | July 01, 2015 18:32 IST

The company has also chosen a new corporate colour Purple, which is associated with creativity and wisdom.

Sun Pharma ended flat on US FDA nod

India Infoline News Service | Mumbai | July 01, 2015 16:52 IST

The company gets US FDA nod for anti-allergy drug Levocetirizine Dihydrochloride.

Sequent Scientific gains on approves and consolidation of shareholding in Alivira

India Infoline News Service | Mumbai | July 01, 2015 16:22 IST

The company approved the consolidation of shareholding in Alivira by acquiring all the shares held in Alivira from Unit Trust of India Investment Advisory Services A/c Ascent India Fund III and Devicam Capital LLP i.e., 99,97,941 shares.

Aurobindo Pharma CEO Arvind Vasudeva resigns

India Infoline News Service | Mumbai | July 01, 2015 15:47 IST

The hit a high at Rs. 1,497 and low at Rs. 1,453 on BSE today.

Cadila Healthcare gets USFDA approval for morphine sulfate tablets

India Infoline News Service | Mumbai | July 01, 2015 14:23 IST

The stock has hit a high of Rs. 1,852 and a low of Rs. 1,799 on BSE today.

Metropolis Healthcare strengthens presence in Gujarat

India Infoline News Service | Mumbai | July 01, 2015 12:44 IST

Launches 5th State of the Art Laboratory in the state of GujaratWith the launch of the new lab, Metropolis becomes the only accredited multinational chain of diagnostics to have a presence in Navsari

Sequent Scientific hits 52-week high

India Infoline News Service | Mumbai | July 01, 2015 11:44 IST

The stock has now soared 7 percent, with 2.4-times jump in volume on the BSE counter.

Back to Top

Recent Reports

Weak start to the July series; Sensex, Nifty to open lower

India Infoline Research Team / 08:44, Jun 26, 2015

IIFL is hosting 10 companies at a Management Roadshow in Mumbai today. The opening is a subdued start. US market saw minor losses with Dow, S&P 500 and Nasdaq closing marginally lower.

News